Fulgent Genetics (also operating as Fulgent Diagnostics, Fulgent Therapeutics or simply Fulgent) is an American biotechnology company based in Temple City, California.1)
The Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for Fulgent's COVID-19 RT-PCR testing services on June 11, 2021.2) The EUA also authorized Fulgent to process genetic samples collected using at-home test kits marketed by Picture Genetics3) and Everlywell.4)